v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
License and collaboration revenue $ 4,459 $ 5,370 $ 63,352 $ 12,792
Operating expenses:        
Research and development 70,157 70,333 210,018 202,867
General and administrative 18,924 19,849 58,308 56,984
Total operating expenses 89,081 90,182 268,326 259,851
Loss from operations (84,622) (84,812) (204,974) (247,059)
Gain on sale of ATOM Facility (See Note 7) 0 0 50,237 0
Interest and other income (expense), net 541 148 1,017 283
Total other income (expense), net, Total 541 148 51,254 283
Loss before provision for income taxes (84,081) (84,664) (153,720) (246,776)
Provision for income taxes 10 0 10 16
Net loss (84,091) (84,664) (153,730) (246,792)
Other comprehensive gain (loss):        
Unrealized gain (loss) on available-for-sale securities (341) (38) (2,591) (272)
Comprehensive loss $ (84,432) $ (84,702) $ (156,321) $ (247,064)
Net earnings (loss) per common share:        
Basic earnings (loss) per common share $ (0.82) $ (0.90) $ (1.51) $ (2.67)
Diluted earnings (loss) per common share $ (0.82) $ (0.90) $ (1.51) $ (2.67)
Basic weighted-average shares outstanding 102,423 93,602 101,590 92,411
Diluted weighted-average shares outstanding 102,423 93,602 101,590 92,411

Source